JPH1087512A - Method for real-time inspection of helicobacter pylori infection through urea reagent labeled with 13c - Google Patents

Method for real-time inspection of helicobacter pylori infection through urea reagent labeled with 13c

Info

Publication number
JPH1087512A
JPH1087512A JP8246040A JP24604096A JPH1087512A JP H1087512 A JPH1087512 A JP H1087512A JP 8246040 A JP8246040 A JP 8246040A JP 24604096 A JP24604096 A JP 24604096A JP H1087512 A JPH1087512 A JP H1087512A
Authority
JP
Japan
Prior art keywords
helicobacter pylori
carbon dioxide
gas
isotope
urea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8246040A
Other languages
Japanese (ja)
Inventor
Isao Nishi
功 西
Hitoshi Ishii
均 石井
Yasushi Suzuki
康士 鈴木
Yuichi Ichise
裕一 市瀬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP8246040A priority Critical patent/JPH1087512A/en
Publication of JPH1087512A publication Critical patent/JPH1087512A/en
Pending legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PROBLEM TO BE SOLVED: To avoid errors in measurement, as well as to make packs, etc., unnecessary, steeply shorten the testing time, and increase the number of cases tested, by continuously analyzing expired gas with a fast response gasometric analyzer for expiration and calculating the isotope ratio before and after the dosage of a urea labeled with<13> C. SOLUTION: Before and after oral dosage of a urea labeled with<13> C, a subject is made to hold a tube 1 (e.g. mouthpiece) in his/her mouth and is made to breathe out. Concentrations of<12> CO2 and<13> CO2 (where<13> C is a stable isotope of<12> C) in expired gas are continuously measured at the same time, and the values of the concentrations for a few seconds ending the end of exhaling are known. Then the ratios of<13> CO2 /<12> CO2 for a few seconds ending the end of exhaling are calculated and the mean value of these ratios is calculated at the end of exhaling. Moreover, the rate of change of<13> CO2 /<12> CO2 before and after dosage of urea labeled with<13> C is calculated and the presence or absence of Helicobacter pylori infection is judged from whether the rate of change is over a set point or not.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、胃壁に寄生するヘ
リコバクターピロリ菌の感染予防の感染の有無を調べる
方法としての「13C標識尿素呼気ガス試験」を原理とす
る試験の方法に関する。
The present invention relates to a test method based on the principle of " 13C- labeled urea breath gas test" as a method for examining the presence or absence of infection for prevention of Helicobacter pylori infection on the stomach wall.

【0002】[0002]

【従来の技術】ヘリコバクターピロリ菌は尿素に暴露さ
れると、これを加水分解して炭酸ガスとアンモニアを発
生させる。この炭酸ガスの構成元素である炭酸(C)は
尿素の構成元素である炭酸(C)に由来するものであ
る。従って、尿素の構成元素である炭酸13Cによってマ
ークを付ければ、呼気中の炭酸ガスを計測する事で、尿
素が分解されたかどうか判明する。これによってヘリコ
バクターピロリ菌の介在を知ることができる。従来、こ
の試験方法は、尿素の構成元素の炭酸に安定同位体であ
13Cをラベルした13C標識尿素を使用し、これを経口
投与する前及び後において、それぞれバック等に呼気を
呼出させ蓄えた上で、このガスをガス分析計で分析し、
この炭酸ガスの同位体比(13CO2/12CO2)を算出し、この
同位体比の13C標識尿素投与前後の変化率を調べ、設定
した変化率を越えたかを判断し菌感染の有無を判定して
いた。
2. Description of the Related Art When Helicobacter pylori is exposed to urea, it is hydrolyzed to generate carbon dioxide and ammonia. Carbonic acid (C) which is a constituent element of the carbon dioxide gas is derived from carbonic acid (C) which is a constituent element of urea. Therefore, if a mark is made with carbonic acid 13 C, which is a constituent element of urea, it is possible to determine whether or not urea has been decomposed by measuring the carbon dioxide gas in the breath. This makes it possible to know the presence of Helicobacter pylori. Conventionally, this test method uses 13 C-labeled urea labeled with 13 C, which is a stable isotope of carbonic acid, a constituent element of urea, and exhales the bag before and after oral administration. After storing, this gas is analyzed with a gas analyzer,
Calculating the isotope ratio of carbon dioxide (13 CO 2/12 CO 2 ), we examined the 13 C-labeled urea administered before and after the change rate of the isotope ratio, the infection to determine exceeds the rate of change set The presence or absence was determined.

【0003】[0003]

【発明が解決しようとする課題】従来の試験方法では、
一度パック等に呼気ガスを蓄える事を行うため、標識尿
素投与前後で1つずつパックが必要としコストがかかる
事、このパックを再利用しようとすると、滅菌処理を施
さなければならず、手間が生じていた。また、試験結果
を導き出すのに時間がかかり、試験処理数に限界があっ
た。またパックに採気する際、息を吐き出すとき初めの
うちは吸い込んだ空気で肺まで到達してガス交換に寄与
した呼気いわゆる肺胞気ではなく、空気そのものが吐き
出されるため、呼気中に含まれる炭酸ガス同位体比の変
化を分析する本試験方法にあっては、空気中の炭酸ガス
と混合して誤差を生じていた。
In the conventional test method,
Once the expiration gas is stored in a pack etc., one pack is required before and after the administration of labeled urea, which is costly. If this pack is to be reused, sterilization must be performed, which is troublesome. Had occurred. In addition, it takes time to derive test results, and the number of test processes is limited. In addition, when inhaling the pack, when exhaling, the exhaled air reaches the lungs at first and contributes to gas exchange. In this test method for analyzing a change in gas isotope ratio, an error was caused by mixing with carbon dioxide in air.

【0004】本発明は、パック等を利用せず、応答速度
の速い呼気ガス分析計を用い呼気ガスを呼出過程で、呼
出終了時までの数秒間、炭酸ガス濃度を連続的に分析し
同位体比を算出することで、パックを必要とせず、試験
時間を大幅に短縮し、試験処理件数を増加させ、さらに
測定誤差をなくす試験方法を提供する。
The present invention uses a breath gas analyzer having a high response speed without using a pack or the like, and continuously analyzes the carbon dioxide gas concentration for several seconds until the end of the breath by using a breath gas analyzer having a high response speed and isotope. By calculating the ratio, there is provided a test method that does not require a pack, greatly reduces test time, increases the number of test processes, and further eliminates measurement errors.

【0005】[0005]

【課題を解決するための手段】本発明による13C標識尿
素試薬によるリアルタイムヘリコバクターピロリ感染検
査方法は、ヘリコバクターピロリ菌の感染を調べる「13
C標識尿素呼気ガス試験」であって、13C標識尿素を経
口投与する前後において、被験者にマウスピース等の筒
(1)を口に加えさせ、息を呼出させ、高速応答性能を持
ったガス分析計により呼気中の炭酸ガス(12CO2)および
その安定同位体(13CO2)の濃度を同時連続的に計測する
事と、呼出終了時までの数秒間の各ガス濃度値を認識す
る事と、呼出終了時までの数秒間の炭酸ガス同位体比(
13CO2/12CO2)を算出する事と、呼出終了時に呼出終了時
までの数秒間の炭酸ガス同位体比(13CO2/12CO2)の平均
値を算出する事と、13C標識尿素投与前後の炭酸ガス同
位体比(13CO2/12CO2)の変化率を算出する事と、この変
化率が設定した値を越えたか否かを判定する事によっ
て、ヘリコバクターピロリの感染の有無を決定する方法
である。
Real-time Helicobacter pylori infection inspection method according to 13 C-labeled urea reagent according to the present invention, in order to solve the problems] examines the infection of Helicobacter pylori "13
In the “C-labeled urea breath gas test”, the subject was given a tube such as a mouthpiece before and after oral administration of 13 C-labeled urea.
(1) is added to the mouth, breath is exhaled, and the concentration of carbon dioxide ( 12 CO 2 ) and its stable isotope ( 13 CO 2 ) in the breath is simultaneously and continuously measured by a gas analyzer with high-speed response performance. Measurement, recognizing each gas concentration value for several seconds until the end of the call, and carbon dioxide isotope ratio (
13 CO 2/12 CO 2) that calculates a, and calculating the average value of the carbon dioxide gas isotope several seconds until the call terminated at the call termination (13 CO 2/12 CO 2 ), 13 C and calculating the rate of change of the carbon dioxide gas isotope ratio across labeled urea administered (13 CO 2/12 CO 2 ), by determining whether or not exceed the value of this rate of change set, infection of Helicobacter pylori Is a method of determining the presence or absence of the

【0006】[0006]

【発明の実施の形態】以下、図面と共に本発明による13
C標識尿素試薬によるリアルタイムヘリコバクターピロ
リ感染検査方法の好適な実施の形態について説明する。
図1に示すように、試薬投与前後において被験者にマウ
スピース等の筒1をくわえさせ、ゆっくり1回呼出さ
せ、この時の炭酸ガス濃度変化を質量分析計等の高速応
答性能を持ったガス分析計で分析する。この時の呼気中
13CO212CO2成分の変化及びその比(13CO2/12CO2)
は図2のようになる。すなわち、図2において、第1相
は、息を呼出する前に吸い込んだ最後の空気が口腔、気
管までしか吸い込まれず、肺にてガス交換に寄与せず
に、呼出により再び排出する相で、炭酸ガスに変化は認
められず、空気と同等の濃度で推移する。第2相は肺に
てガス交換に寄与したガスと口腔、気管にてガス交換に
寄与していないガスとの混合相である。パックに呼気ガ
スを採気した場合、この第1相及び第2相が混ざり込む
ため、ガス交換によるガス濃度値が空気のガス濃度値と
混ざり合い、測定誤差を生む原因となる。第3相は、肺
においてガス交換に寄与したガスが吐き出された相であ
り、この時の炭酸ガス同位体比(13CO2/12CO2)は図2に
示すように一定値を示す。この第3相の同位体比が一定
となった試薬投与後の値が試薬投与前後の値に比較し一
定のしきい値を越えたかどうかによってヘリコバクター
ピロリ菌の感染の有無を決定する。
DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, the present invention in conjunction with the accompanying drawings 13
A preferred embodiment of a real-time Helicobacter pylori infection test method using a C-labeled urea reagent will be described.
As shown in FIG. 1, before and after the administration of the reagent, the subject holds the tube 1 such as a mouthpiece and slowly calls it once. The change in the carbon dioxide concentration at this time is analyzed by a gas analyzer having a high-speed response such as a mass spectrometer. Analyze in total. During exhalation at this time
13 CO 2 and 12 CO 2 component change and the ratio of (13 CO 2/12 CO 2 )
Is as shown in FIG. That is, in FIG. 2, the first phase is a phase in which the last air inhaled before exhalation is inhaled only to the oral cavity and the trachea and does not contribute to gas exchange in the lungs, but is exhaled again by exhalation. There is no change in carbon dioxide gas, and the concentration changes at the same level as air. The second phase is a mixed phase of gas that has contributed to gas exchange in the lungs and gas that has not contributed to gas exchange in the oral cavity and trachea. When exhalation gas is collected in the pack, the first phase and the second phase are mixed, so that the gas concentration value due to gas exchange is mixed with the gas concentration value of air, which causes a measurement error. The third phase, a phase gas contributing to gas exchange in the lungs is exhaled carbon dioxide isotope ratio when the (13 CO 2/12 CO 2 ) indicates a constant value as shown in FIG. The presence or absence of Helicobacter pylori infection is determined based on whether or not the value after the administration of the reagent at which the isotope ratio of the third phase becomes constant exceeds a predetermined threshold value as compared with the value before and after the administration of the reagent.

【0007】[0007]

【発明の効果】本発明により、試験時間が短縮され、試
験のために必要な部品(パック等)を必要としないた
め、試験処理件数を大幅に増加させる事が可能となる。
また、呼出過程で空気の混合の有無をモニターし、純す
いに肺胞気炭酸ガスのみの同位体比を分析することがで
きるため、試験精度を向上させる事ができる。
According to the present invention, the test time can be shortened, and parts (packs and the like) required for the test are not required, so that the number of test processes can be greatly increased.
Further, the presence or absence of air mixing can be monitored during the exhalation process, and the isotope ratio of only alveolar carbon dioxide can be analyzed purely, so that the test accuracy can be improved.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明の測定の方法を示す越す製図である。FIG. 1 is a cross-drawing diagram illustrating the method of measurement of the present invention.

【図2】測定により得られる炭酸ガス12CO213CO2の濃
度の変化の様態及び炭酸ガス同位体比の変化を示す特性
図である。
FIG. 2 is a characteristic diagram showing a state of a change in concentrations of carbon dioxide 12 CO 2 and 13 CO 2 and a change in carbon dioxide isotope ratio obtained by measurement.

【符号の説明】[Explanation of symbols]

1 筒 1 cylinder

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 ヘリコバクターピロリ菌の感染を調べる
13C標識尿素呼気ガス試験」であって、13C標識尿素
を経口投与する前後において、被験者にマウスピース等
の筒(1)を口に加えさせ、息を呼出させ、高速応答性能
を持ったガス分析計により呼気中の炭酸ガス(12CO2)お
よびその安定同位体(13CO2)の濃度を同時連続的に計測
する事と、呼出終了時までの数秒間の各ガス濃度値を認
識する事と、呼出終了時までの数秒間の炭酸ガス同位体
比(13CO2/12CO2)を算出する事と、呼出終了時に呼出終
了時までの数秒間の炭酸ガス同位体比(13CO2/12CO2)の
平均値を算出する事と、13C標識尿素投与前後の炭酸ガ
ス同位体比(13CO2/12CO2)の変化率を算出する事と、こ
の変化率が設定した値を越えたか否かを判定する事によ
って、ヘリコバクターピロリの感染の有無を決定するこ
とを特徴とする13C標識尿素試薬によるリアルタイムヘ
リコバクターピロリ感染検査方法。
1. A " 13C- labeled urea breath gas test" for examining Helicobacter pylori infection, in which a mouthpiece or other tube (1) is added to a subject before and after oral administration of 13C- labeled urea. Simultaneously and continuously measure the concentration of carbon dioxide ( 12 CO 2 ) and its stable isotope ( 13 CO 2 ) in the exhaled breath using a gas analyzer with high-speed response and possible to recognize each gas concentration value of a few seconds up to the end, and that the calculating few seconds CO isotope to at call ends (13 CO 2/12 CO 2 ), call termination at call termination carbon dioxide isotope several seconds until (13 CO 2/12 CO 2 ) of the possible to calculate the mean value, 13 C-labeled urea carbon dioxide isotope before and after administration (13 CO 2/12 CO 2 ) By calculating the rate of change of the helicopter and determining whether the rate of change exceeds a set value. Real-time Helicobacter pylori infection inspection method according to 13 C-labeled urea reagent and determining the presence or absence of infection of H..
JP8246040A 1996-09-18 1996-09-18 Method for real-time inspection of helicobacter pylori infection through urea reagent labeled with 13c Pending JPH1087512A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8246040A JPH1087512A (en) 1996-09-18 1996-09-18 Method for real-time inspection of helicobacter pylori infection through urea reagent labeled with 13c

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8246040A JPH1087512A (en) 1996-09-18 1996-09-18 Method for real-time inspection of helicobacter pylori infection through urea reagent labeled with 13c

Publications (1)

Publication Number Publication Date
JPH1087512A true JPH1087512A (en) 1998-04-07

Family

ID=17142570

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8246040A Pending JPH1087512A (en) 1996-09-18 1996-09-18 Method for real-time inspection of helicobacter pylori infection through urea reagent labeled with 13c

Country Status (1)

Country Link
JP (1) JPH1087512A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007034948A1 (en) 2005-09-26 2007-03-29 Ako Kasei Co., Ltd. Method of inhibiting the proliferation and migration of helicobacter pylori
JP2015511009A (en) * 2012-03-07 2015-04-13 ウィスコンシン アルムニ リサーチ ファンデイション Detecting the rate of change in regular changes in metabolic pathways by monitoring isotope ratios
CN109259738A (en) * 2018-10-31 2019-01-25 上海健康医学院 A kind of mask for positron radionuclide count detection instrument
CN117665222A (en) * 2024-02-01 2024-03-08 中国计量科学研究院 Calibration device and method for helicobacter pylori carbon 13 detection equipment

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007034948A1 (en) 2005-09-26 2007-03-29 Ako Kasei Co., Ltd. Method of inhibiting the proliferation and migration of helicobacter pylori
JP2015511009A (en) * 2012-03-07 2015-04-13 ウィスコンシン アルムニ リサーチ ファンデイション Detecting the rate of change in regular changes in metabolic pathways by monitoring isotope ratios
CN109259738A (en) * 2018-10-31 2019-01-25 上海健康医学院 A kind of mask for positron radionuclide count detection instrument
CN117665222A (en) * 2024-02-01 2024-03-08 中国计量科学研究院 Calibration device and method for helicobacter pylori carbon 13 detection equipment
CN117665222B (en) * 2024-02-01 2024-04-26 中国计量科学研究院 Verification method for helicobacter pylori carbon 13 detection equipment

Similar Documents

Publication Publication Date Title
Wilson Breath analysis: physiological basis and sampling techniques
CN101340941B (en) Method and apparatus for estimating lung volume at the end of exhalation
Borland et al. A simultaneous single breath measurement of pulmonary diffusing capacity with nitric oxide and carbon monoxide
Bartels et al. The respiratory dead space measured by single breath analysis of oxygen, carbon dioxide, nitrogen or helium
US9186090B2 (en) Method and system for DLCO quality control testing
JPH07155379A (en) Method to determine residual capacity of lung which functions, and device for ventilation to determine functioning residual capacity
Cerretelli et al. Determination of mixed venous O2 and CO2 tensions and cardiac output by a rebreathing method
Jensen et al. A metabolic cart for measurement of oxygen uptake during human exercise using inspiratory flow rate
US20070125378A1 (en) Method and apparatus for producing an average signal characteristic profile from cyclically recurring signals
US4300384A (en) Method and apparatus for taking samples for the determination of breath alcohol content
EP1153294A1 (en) Indicator device
JP6099249B2 (en) Exhalation gas analyzer
JPH1087512A (en) Method for real-time inspection of helicobacter pylori infection through urea reagent labeled with 13c
Koenig et al. Bronchoconstrictor responses to sulfur dioxide or sulfur dioxide plus sodium chloride droplets in allergic, nonasthmatic adolescents
Barrow et al. NH3 concentrations in the expired air of the rat: Importance to inhalation toxicology
JP2003232732A (en) Isotopic gas measuring instrument
Barter Capnography
US7387609B2 (en) Method of measuring absolute lung volume based on O2/CO2 gas analysis
Moutafis et al. Validation of a simple method assessing nitric oxide and nitrogen dioxide concentrations
JP3014652B2 (en) Isotope gas spectrometry
US20070173729A1 (en) Simple approach to precisely 02 consumption, and anesthetic absorption during low flow anesthesia
CN110522451A (en) The measurement method and system of CO diffusing capacity in multicomponent gas
JP3065498B2 (en) Breath collection device
Williams et al. Measurement of dead–space in a model lung using an oscillating inspired argon signal
Neville et al. A standardised method of estimating KCO on exercise.

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060926

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070206